human MYL2 (NM_000432) lentivirus particles

Name: human MYL2 (NM_000432) lentivirus particles
SKU: LV18950L
Availability: InStock

For research use only. Not intended for any clinical use.

Cat. No. : LV18950L

Storage : -80℃ Shipping : Frozen on dry ice

Titer: Size:

Inquire for Price

Virus Particles Information

Quality Control

Gene Information

Cat. No.	LV18950L
Description	Lentiviral particles of myosin, light chain 2, regulatory, cardiac, slow (MYL2).
Product Type	Premade Lentivirus Particles
Gene	MYL2
Species	Human
Insert Size	501 bp
Titer	Varies lot by lot, for example, ≥110^7 TU/mL, ≥110^8 TU/mL, ≥1*10^9 TU/mL etc.
Size	Varies lot by lot, for example, 100 ul, 500 ul, 1 mL etc.
Storage	Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping	Frozen on dry ice

Summary	Creative Biogene ensures high-quality lentivirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between lentivirus particle lots.
Mycoplasma	Creative Biogene routinely tests for mycoplasma contamination using a mycoplasma detection kit. Cell lines are maintained for approximately 20 passages before being discarded and replaced with a new vial of early passage cells. Approximately 2 weeks after thawing, cell culture supernatants are tested for mycoplasma contamination. Creative Biogene ensures that lentiviral products are free of mycoplasma contamination.
Purity	Creative Biogene evaluates the level of impurities, such as residual host cell DNA or proteins, in prepared lentiviral vectors to ensure they meet quality standards.
Sterility	The lentiviral samples were inoculated into cell culture medium for about 5 days and the growth of bacteria and fungi was tested. Creative Biogene ensures that the lentiviral products are free of microbial contamination.
Transducibility	Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of lentivirus to deliver genetic material into target cells, and assess gene expression and functional activities.
Proviral Identity Confirmation	All Creative Biogene lentiviral vectors are confirmed to have correctly integrated provirus using PCR. This test involves transducing cells with serial dilutions of the lentiviral vector, harvesting the cells a few days later, and isolating genomic DNA. This DNA is then used as a template to amplify a portion of the expected lentiviral insert.

Gene Name	MYL2 myosin, light chain 2, regulatory, cardiac, slow [ Homo sapiens ]
Gene Symbol	MYL2
Synonyms	MYL2; myosin, light chain 2, regulatory, cardiac, slow; myosin, light polypeptide 2, regulatory, cardiac, slow; myosin regulatory light chain 2, ventricular/cardiac muscle isoform; cardiac ventricular myosin light chain 2; CMH10; MLC-2; MLC-2v; RLC of myosin; myosin light chain 2; regulatory light chain of myosin; slow cardiac myosin regulatory light chain 2; MLC2; DKFZp779C0562;
Gene ID	4633
Uni Prot ID	P10916
m RNA Refseq	BC015821
Chromosome Location	12q24.11
Function	actin monomer binding; calcium ion binding; myosin heavy chain binding; protein binding; structural constituent of muscle;
Pathway	CDC42 signaling events, organism-specific biosystem; Cardiac muscle contraction, organism-specific biosystem; Cardiac muscle contraction, conserved biosystem; Dilated cardiomyopathy, organism-specific biosystem; Dilated cardiomyopathy, conserved biosystem; Focal adhesion, organism-specific biosystem; Focal adhesion, conserved biosystem;
MIM	160781

Quick Inquiry

Q & A

Customer Reviews

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Question *

Name

Country *

Email *

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Product Name *

Catalog Name *

Rating

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

Product Review Title *

Summary *